FindTrial
Sign In

Evaluate of wound healing by Transepidermal water loss measurement.

Evaluation of wound healing endpoint and recurrence by transepidermal water loss measurement.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/04/041766
Enrollment
200
Registered
2022-04-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

AIIMSRishikesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Chronic wound of multiple etiologies and open for at least 30 days

Exclusion criteria

Exclusion criteria: Individuals who are deemed unable to provide informed consent. Diabetics with Hemoglobin A1c > 10% Subjects with marked immunodeficiency

Design outcomes

Primary

MeasureTime frame
bone reopeningTimepoint: Baseline, 2 weeks, 4 weeks, 6 weeks—

Secondary

MeasureTime frame
Measurement of TEWL in normal skin and TEWL measurement in wounds reopeningTimepoint: Eight weeks—

Countries

India

Contacts

Public ContactDr Akshay Kapoor

AIIMS, Rishikesh

debarati1981@gmail.com9433834487

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026